Price Chart

Profile

Syntara Ltd. is a clinical stage drug development company which engages in the development of healthcare products for haematological diseases. Its lead compounds include amsulostat (SNT-5055) and topical pan-LOX inhibitors with SNT-9495. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.
URL http://syntaratx.com.au
Investor Relations URL N/A
HQ State/Province New South Wales (NSW)
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Syntara Ltd. is a clinical stage drug development company which engages in the development of healthcare products for haematological diseases. Its lead compounds include amsulostat (SNT-5055) and topical pan-LOX inhibitors with SNT-9495. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.
URL http://syntaratx.com.au
Investor Relations URL N/A
HQ State/Province New South Wales (NSW)
Sector  
Industry  
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A